Related Experiment Videos
Increased platelet aggregation and release reaction in myotonic dystrophy
N M Bornstein1, M Zahavi, A D Korczyn
1Department of Neurology, Tel Aviv University, Ramat Aviv, Israel.
Journal of the Neurological Sciences
|April 1, 1988
Summary
Patients with myotonic dystrophy (MyD) show heightened platelet aggregation (PA) and release reactions. This suggests platelet dysfunction, potentially linked to alpha 2-receptor and calcium channel abnormalities in MyD.
Area of Science:
- Hematology
- Neurology
- Medical Research
Background:
- Myotonic dystrophy (MyD) is a multisystem disorder.
- Platelet function abnormalities may contribute to MyD pathophysiology.
- Understanding platelet behavior in MyD is crucial for comprehensive patient care.
Purpose of the Study:
- To investigate platelet aggregation (PA) and release reactions in patients with myotonic dystrophy (MyD).
- To compare platelet function markers between MyD patients and healthy controls.
- To explore potential mechanisms underlying platelet abnormalities in MyD.
Main Methods:
- Studied PA induced by (-)-epinephrine and adenosine diphosphate (ADP) in 16 MyD patients and 14 controls.
- Measured plasma beta-thromboglobulin (beta-TG) levels as a marker of in vivo platelet activation.
- Assessed in vitro 5-[14C]hydroxytryptamine (5-HT) release from platelets.
Main Results:
- MyD patients exhibited significantly higher PA induced by (-)-epinephrine and ADP compared to controls.
- Elevated plasma beta-TG levels were observed in MyD patients, indicating increased in vivo platelet release.
- Increased ADP- and epinephrine-induced platelet 5-HT release was noted in MyD patients.
Conclusions:
- Platelets in MyD patients display enhanced aggregation and release reactions.
- Findings suggest abnormalities in alpha 2-receptor function and platelet release mechanisms in MyD.
- Potential alterations in platelet membrane calcium (Ca2+) fluxes may be involved in MyD-related platelet dysfunction.